{"id":10760,"date":"2020-02-04T14:43:32","date_gmt":"2020-02-04T09:13:32","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=10760"},"modified":"2026-07-30T22:02:36","modified_gmt":"2026-07-30T16:32:36","slug":"catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/","title":{"rendered":"Catalent&#8217;s Shopping List: Towards a One-Stop Cell &#038; Gene Therapy CMO"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">There appear to be no Monday blues for Catalents as the company announces the <a href=\"https:\/\/www.businesswire.com\/news\/home\/20200203005176\/en\/%C2%A0Catalent-Acquire-Leading-Cell-Therapy-Company-MaSTherCell\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">acquisition of MaSTherCell Global<\/a>, a technology-focused cell and gene therapy contract development and manufacturing organization. Following its last year&#8217;s acquisition of <a href=\"https:\/\/www.catalent.com\/catalent-news\/catalent-to-acquire-gene-therapy-leader-paragon-bioservices-inc-for-1-2-billion\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Paragon Bioservices<\/a> (a leading <a aria-label=\"viral vector developer (opens in a new tab)\" href=\"https:\/\/www.rootsanalysis.com\/blog\/2019\/10\/10\/growing-cell-and-gene-therapy-market-vector-manufacturers-make-merry\/\" target=\"_blank\" rel=\"noreferrer noopener\">viral vector developer<\/a>), Recent acquisition by Catalent in Gene Therapy segment has extended the company\u2019s leadership in this already crowded space.<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-rich is-provider-x wp-block-embed-x\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Catalent Chairman and CEO John Chiminski triggers a $315M-plus wager on the booming cell therapy market now in the making. Read the full interview: <a href=\"https:\/\/t.co\/m3UL8ynRn3\">https:\/\/t.co\/m3UL8ynRn3<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/celltherapy?src=hash&amp;ref_src=twsrc%5Etfw\">#celltherapy<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/biotech?src=hash&amp;ref_src=twsrc%5Etfw\">#biotech<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/acquisition?src=hash&amp;ref_src=twsrc%5Etfw\">#acquisition<\/a> <a href=\"https:\/\/t.co\/gV3dL4B1zk\">pic.twitter.com\/gV3dL4B1zk<\/a><\/p>&mdash; Catalent Pharma (@CatalentPharma) <a href=\"https:\/\/twitter.com\/CatalentPharma\/status\/1224361226022588416?ref_src=twsrc%5Etfw\">February 3, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why has there been so much interest in this space?<\/strong> <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The increasing acquisition activity in this space is heavily driven by the growing pipeline of cell-based therapies. With more than 600 candidates in development, the cell therapy space has witnessed significant interest from various stakeholders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The development pipeline of cell-based therapies is very attractive and features a number of big pharma players. However, the manufacturing challenges associated with these therapies has acted as a roadblock.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"162\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\" alt=\"Catalents - Cell Therapy Manufacturing Challenges\" class=\"wp-image-17458\" style=\"object-fit:contain;width:800px;height:128px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp 1024w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots-300x47.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots-768x122.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Manufacturing cell therapies is technically and financially demanding. Therefore, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers. In fact, over 100 industry players and 60 non-industry players currently claim to manufacture different types of cell therapies.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"158\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Current-Market-Landscape-and-Upcoming-Trends-in-Cell-Therapy-Manufacturing-Roots.webp\" alt=\"Current market scenario and future Trends in Cell Therapy Manufacturing\" class=\"wp-image-17460\" style=\"object-fit:contain;width:800px;height:124px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Current-Market-Landscape-and-Upcoming-Trends-in-Cell-Therapy-Manufacturing-Roots.webp 1024w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Current-Market-Landscape-and-Upcoming-Trends-in-Cell-Therapy-Manufacturing-Roots-300x46.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Current-Market-Landscape-and-Upcoming-Trends-in-Cell-Therapy-Manufacturing-Roots-768x119.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why is Catalents acquiring so many players in gene therapy?<\/strong> <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The acquisition of MaSTherCell is a strategic move to extend the service offerings for cell and gene therapies. Here is what the company&#8217;s CEO said about the acquisition:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"> \u201cMaSTherCell extends our leadership position in the biotech industry, complements our leading gene therapy offering, and allows us to deliver comprehensive development, manufacturing, analytical, fill-finish, and clinical supply solutions for innovators across the large molecule space\u201d <\/p>\n<cite> &#8211; John Chiminski, Catalent\u2019s Chair &amp; Chief Executive Officer <\/cite><\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">The move has allowed the company to set itself apart in the highly competitive cell and gene therapy manufacturing space.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To get detailed insights about the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/cell-therapy-manufacturing\/285.html\">cell therapy manufacturing market<\/a>, check out the detailed report Cell Therapy Manufacturing. For details on the gene therapy market, check out <a href=\"https:\/\/www.rootsanalysis.com\/blog\/10320\/\" target=\"_blank\" rel=\"noreferrer noopener\">this infographic<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">An in-depth analysis of the various cell therapy manufacturing focused initiatives undertaken by big pharma players, based on several relevant parameters, such as number of initiatives, year of initiative, purpose of initiative, type of initiative, scale of operation and type of cell manufactured.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>There appear to be no Monday blues for Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization. Following its last year&#8217;s acquisition of Paragon Bioservices (a leading viral vector developer), Recent acquisition by Catalent in Gene Therapy segment has extended the company\u2019s leadership [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[118,47],"tags":[194,153,48,152],"class_list":["post-10760","post","type-post","status-publish","format-standard","hentry","category-cell-therapy","category-gene-therapy","tag-biopharma-contract-manufacturing","tag-cell-therapy","tag-gene-therapy","tag-vector-manufacturing"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Catalents - Towards a One-Stop Cell &amp; Gene Therapy CMO<\/title>\n<meta name=\"description\" content=\"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalents - Towards a One-Stop Cell &amp; Gene Therapy CMO\" \/>\n<meta property=\"og:description\" content=\"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-04T09:13:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-30T16:32:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"162\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Gaurav Chaudhary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gaurav Chaudhary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/\"},\"author\":{\"name\":\"Gaurav Chaudhary\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\"},\"headline\":\"Catalent&#8217;s Shopping List: Towards a One-Stop Cell &#038; Gene Therapy CMO\",\"datePublished\":\"2020-02-04T09:13:32+00:00\",\"dateModified\":\"2026-07-30T16:32:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/\"},\"wordCount\":373,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\",\"keywords\":[\"Biopharma Contract Manufacturing\",\"Cell Therapy\",\"Gene Therapy\",\"Vector Manufacturing\"],\"articleSection\":[\"Cell Therapy\",\"Gene Therapy\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/\",\"name\":\"Catalents - Towards a One-Stop Cell & Gene Therapy CMO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\",\"datePublished\":\"2020-02-04T09:13:32+00:00\",\"dateModified\":\"2026-07-30T16:32:36+00:00\",\"description\":\"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp\",\"width\":1024,\"height\":162},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalent&#8217;s Shopping List: Towards a One-Stop Cell &#038; Gene Therapy CMO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\",\"name\":\"Gaurav Chaudhary\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"caption\":\"Gaurav Chaudhary\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catalents - Towards a One-Stop Cell & Gene Therapy CMO","description":"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/","og_locale":"en_US","og_type":"article","og_title":"Catalents - Towards a One-Stop Cell & Gene Therapy CMO","og_description":"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development","og_url":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2020-02-04T09:13:32+00:00","article_modified_time":"2026-07-30T16:32:36+00:00","og_image":[{"width":1024,"height":162,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp","type":"image\/webp"}],"author":"Gaurav Chaudhary","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Gaurav Chaudhary","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/"},"author":{"name":"Gaurav Chaudhary","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc"},"headline":"Catalent&#8217;s Shopping List: Towards a One-Stop Cell &#038; Gene Therapy CMO","datePublished":"2020-02-04T09:13:32+00:00","dateModified":"2026-07-30T16:32:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/"},"wordCount":373,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp","keywords":["Biopharma Contract Manufacturing","Cell Therapy","Gene Therapy","Vector Manufacturing"],"articleSection":["Cell Therapy","Gene Therapy"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/","url":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/","name":"Catalents - Towards a One-Stop Cell & Gene Therapy CMO","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp","datePublished":"2020-02-04T09:13:32+00:00","dateModified":"2026-07-30T16:32:36+00:00","description":"Catalents as the company announces the acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Cell-and-Gene-Therapy-Manufacturing-Challenges-Roots.webp","width":1024,"height":162},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Catalent&#8217;s Shopping List: Towards a One-Stop Cell &#038; Gene Therapy CMO"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc","name":"Gaurav Chaudhary","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","caption":"Gaurav Chaudhary"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=10760"}],"version-history":[{"count":6,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10760\/revisions"}],"predecessor-version":[{"id":22670,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/10760\/revisions\/22670"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=10760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=10760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=10760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}